NFKB1 and ischemic stroke: In addition to the classical NF-κB pathway the mechanism of Triptolide treatment in ischemic stroke also involves inhibition of inflammatory responses mediated by activation of the Wnt/β-catenin signaling pathway (Pan and Xu, 2020).